Loading article…
Google introduced a $99 Fitbit Air wearable and a Gemini‑powered AI health coach at $9.99/month, sparking a fast rival response from Whoop.
Google rolled out the Fitbit Air, a $99 screenless tracker, together with a Gemini‑based AI health coach that costs $9.99 per month, positioning the service as the core of its new Google Health app launch on May 19 – May 26 [1][3]. The move pits an AI‑first interpretation of biometric data against Whoop’s human‑clinician model announced just a day later, highlighting a split strategy in the wearable health market.
| At a glance | |
|---|---|
| Device | Fitbit Air, $99 screenless tracker |
| Launch window | May 19 – May 26 (app rollout) |
| AI coach price | $9.99 per month (Google Health Premium) |
| Competitor response | Whoop adds on‑demand clinician video consultations |
The Fitbit Air is a 1.4‑inch‑by‑0.7‑inch plastic puck that fits into interchangeable bands, including a Stephen Curry special edition, and lacks any display. Google says the device can run about a week on a single charge and store a day of data offline before syncing to a phone [2]. All sensor data—heart rate, HRV, SpO₂, sleep stages, and activity—is accessed through the newly branded Google Health app, which replaces the Fitbit app on May 19 [3].
The AI health coach, built on Google’s Gemini model, is bundled with a three‑month free trial of Google Health Premium. After the trial, the service costs $9.99 per month or $99 per year and promises personalized workout plans, sleep trend analysis, medical record summarization, and answers to health queries [3]. Google frames the AI as the “intelligence layer” that can sit between any wearable sensor and health decisions, with future support planned for Apple Watch, Oura, and Garmin devices later this year [3].
One day after Google’s announcement, Whoop unveiled a contrasting approach: adding on‑demand video consultations with licensed clinicians to its platform. Whoop’s service will let users review continuous biometric data collected by Whoop bands and, if synced, blood work and medical history, before a clinician provides context and recommendations [3]. The rapid response underscores a philosophical divide—Google bets on AI to interpret data, while Whoop leans on human expertise to validate it.
Both companies cite the U.S. FDA’s relaxed oversight of AI health tools and consumer wearables, introduced in January, as a backdrop for their strategies [3]. The market now faces a choice between an AI chatbot that can flag a declining HRV trend and a doctor who can explain the underlying cause.
Google’s entry signals a bold bet that AI can replace the clinician’s role in everyday health guidance, while Whoop’s counter‑move suggests the market may still value human oversight. The coming months will reveal which model users trust with their biometric data.
Coverage is mostly measured — 84 of 96 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 3 outlets · Jun 18, 2026 · How we report
Google AI was announced at Google I/O 2017 by CEO Sundar Pichai.
In 2023, Google Brain merged with DeepMind, and Jeff Dean was elevated to chief scientist, creating a unified Google DeepMind entity.
The principles are bold innovation, responsible development and deployment, and collaborative progress, as outlined in the AI Principles document.
TensorFlow, a machine learning library, and the TPU research cloud providing free access to cloud TPUs are open-source initiatives.
The council was abandoned within a month after many Google staff objected to the appointment of Kay Coles James.